NL-OMON36159招募中不适用
Pilot study on the determination of intratumoral concentrations of kinase inhibitors in patients with advanced solid malignancies - Intratumoral kinase inhibitor concentrations in advanced cancer patients
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Advanced solid malignancy, minimum age 18 years, indication for palliative treatment, measurable disease with at least one lesion accessable for biopsy
排除标准
- •Cardiovascular conditions including congestive heartfailure NYHA class >2, recent myocardial infarction or uncontrolled coronary artery disease, cardiac arrhythmias requiring anti-arrhythmic therapy, uncontrolled hypertension; uncontrolled infections; serious non-healing wound, ulcer or bone fracture, pregnant or breast feeding.
研究者
相似试验
尚未招募
不适用
A pilot study to measure the pressure of fluid present around cells of various solid cancer tumors.CTRI/2021/08/035470Tata Memorial Centre
尚未招募
不适用
Pilot study to determine the intraTUMORal OsImertinib concentration in patients with peritoneal metastasizeD colorectal cancer (TUMOROID study)colon cancer1001799110017998Colorectal cancerNL-OMON51641Radboud Universitair Medisch Centrum10
已完成
不适用
Determination of Intratumoral Concentrations of Kinase Inhibitors in Patients With Advanced Solid Malignancies.Advanced Solid TumorsCancerNCT01636908Amsterdam UMC, location VUmc43
终止
1 期
Exploratory Phase Ib/IIa Study of Intratumourally Administered Tigilanol Tiglate to Assess Safety, Tolerability and Tumour Response in Patients with Head and Neck Squamous Cell CarcinomaACTRN12619001407189QBiotics Group Limited19
Unknown
1 期
To study the Safety, Tolerability and Tumour Response when treated with drug Tigilanol Tiglate administered intratumourally in Patients with Head and Neck Squamous Cell Carcinoma.CTRI/2019/11/022032QBiotics Group Limited13